Michael Cruse - Aug 25, 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Senior VP-Corporate Operations
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Aug 25, 2021
Transactions value $
$18,616
Form type
4
Date filed
8/26/2021, 05:51 PM
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Purchase $18.6K +2.5K $7.45 2.5K Aug 25, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction was $7.4464. The shares were purchased at a range of prices between $7.425 and $7.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.